Long Term Safety Throughout 18 month treatment period [clinicaltrials_resource:75066fe6467ea15c6153a9453eddda0f]

Long Term Safety Throughout 18 month treatment period [clinicaltrials_resource:75066fe6467ea15c6153a9453eddda0f]

10mg Tablet, oral Daily for 18 months
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:75066fe6467ea15c6153a9453eddda0f
Safety of Treatment of Uterine Fibroids With Asoprisnil [clinicaltrials:NCT00156208]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]

Long Term Safety Throughout 18 month treatment period [clinicaltrials_resource:75066fe6467ea15c6153a9453eddda0f]

10mg Tablet, oral Daily for 18 months
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
Secondary outcome [clinicaltrials_vocabulary:secondary-outcome]
http://bio2rdf.org/clinicaltrials_resource:75066fe6467ea15c6153a9453eddda0f
Bio2RDF identifier
75066fe6467ea15c6153a9453eddda0f
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:75066fe6467ea15c6153a9453eddda0f
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
Throughout 18 month treatment period
description
10mg Tablet, oral Daily for 18 months
identifier
clinicaltrials_resource:75066fe6467ea15c6153a9453eddda0f
title
Long Term Safety Throughout 18 month treatment period
@en
inDataset
type
label
Long Term Safety Throughout 18 ...... 66fe6467ea15c6153a9453eddda0f]
@en